BackNxera Pharma , Ltd. Overview

Nxera Pharma , Ltd. Net Tangible Assets

Nxera Pharma , Ltd.'s net tangible assets is $64B.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$64.33B
↓ 2.32% YoYΔ $-1.53B vs prior year quarter

Peer trimmed avg / median

Loading

Nxera Pharma , Ltd. Net Tangible Assets History

Loading

Nxera Pharma , Ltd. vs. peers: Net Tangible Assets Comparison

Loading

Nxera Pharma , Ltd. Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Nxera Pharma , Ltd. (SOLTF) FAQ

As of the most recent data (June 2026), SOLTF shows a net tangible assets of $64B. That compares with $66B in the prior-year period — down 2.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SOLTF's net tangible assets is now $64B (was $66B) — a 2.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Nxera Pharma , Ltd. is outperforming or lagging.

Tracking SOLTF's net tangible assets over time shows whether Nxera Pharma , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $64B That compares with $66B in the prior-year period — down 2.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Nxera Pharma , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $64B) with ownership activity and broader fundamentals.

Nxera Pharma , Ltd.'s net tangible assets is $64B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.